Advertisement

Topics

Companies Related to "Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery" [Most Relevant Company Matches] RSS

06:17 EST 23rd February 2019 | BioPortfolio

Here are the most relevant search results for "Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery" found in our extensive corporate database of over 50,000 company records.

Showing "Role Neural Hormonal Regulation Factors Insulin Secretion After" Companies 1–25 of 941

Relevant

ibt - immunological & biochemical testsystems GmbH

ibt - immunological and biochemical testsystems GmbH is a company dedicated to supply the scientific community with reagents and assays. Our reagents are recombinant proteins (viral and bacterial antigens, cytokines and chemokines, growth factors, hormones, transcription factors, tumor markers, enzymes and others) and polyclonal and monoclonal antibodies. Our main interest is in insulin-like grow...


ENDECE Neural

ENDECE Neural is a private biotechnology company at the forefront of developing therapies to repair and potentially reverse damage caused by devastating neurological diseases such as multiple sclerosis (MS). A wholly owned subsidiary of ENDECE LLC, ENDECE Neural was founded in 2011 to focus on the development of what could be the first drug capable of indu...

Waratah Pharmaceuticals

Waratah is a dynamic young biopharmaceutical company founded in April 2000 as a spin-off of RTP Pharma Inc. to develop and commercialize products for its novel, patented therapy – Islet Neogenesis Therapy (I.N.T.™) for the treatment of insulin-dependent diabetes. Diabetes is a disease in which the body does not produce or properly use insulin because of damaged or destroyed insulin producing i...


IBT

ibt develops, manufactures and distributes reagents (monoclonal and polyclonal antibodies, proteins, peptides, antigens) for infectious disease research, transcription, growth factor and cytokine research and assay kits for the detection of growth factors, e.g. insulin-like growth factors (IGF´s) and insulin-like growth factor binding proteins (IGFBP´s).

Tandem Diabetes Care®, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump current...

Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump current...

Medtronic Diabetes

At Medtronic Diabetes, our 20 plus year history vividly reflects our dedication and ongoing vision to develop an "artificial pancreas". In 1983, we pioneered the idea of continuous insulin delivery, introducing our first insulin pump in an effort to find a "better way" to deliver insulin for people with diabetes. Since that time, Medtronic Diabetes has remained the market leader, earning a reputat...

Texas State Board of Pharmacy

To promote, preserve, and protect the public health, safety, and welfare by fostering the provision of quality pharmaceutical care to the citizens of Texas through the regulation of the practice of pharmacy, the operation of pharmacies, and the distribution of prescription drugs in the public interest.The Texas State Board of Pharmacy will assume a leadership role in regulating the practice of pha...

Neural Analytics, Inc.

Neural Analytics was founded in 2013 to create products and services to measure, diagnose and track brain health. The company’s current focus is on acute ischemic stroke, TBI and dementia. They combine leading data science with cutting edge hardware to allow first responders and clinicians to accurately assess and monitor brain health issues. Their de...

MannKind

MannKind is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Our lead investigational product candidate, Technosphere® Insulin System, is currently in phase 3 clinical trials in the U.S. and Europe to study its safety and efficacy in the treatment of diabetes. This therapy consists of a propri...

Repros Therapeutics

We are a biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders. We recently changed the company's name to Repros Therapeutics Inc. from our prior name, Zonagen, Inc., in order to more appropriately reflect our focus on the reproductive and hormonal health technology market.

NiliMEDIX

NiliMEDIX develops innovative durable (to be used for several years) and disposable (replaced every 2-3 days) insulin pumps for helping diabetics manage their diabetes.Insulin pumps deliver insulin the way a healthy pancreas does allowing freedom in daily activities and improving the quality of life of their users.Moreover, the pumps usually decrease the needed daily amount of insulin by reducing ...

Renovo Neural Inc.

Renovo Neural Inc. (http://www.renovoneural.com/) is a privately held company in Cleveland, OH. The company is a specialized research organization providing services to biotech, pharmaceutical and research organizations. Renovo provides a new generation of ultrastructural analyses through its advanced 3D-electron microscopy infrastructure.

Mellitus Health

Founded in 2014 as Insulin Algorithms by Mayer Davidson, MD, Josh Davidson and Michael Margolese, the Los Angeles firm rebranded in 2018 as Mellitus Health, Inc. Its cloud-based insulin titration software works with all insulins and combinations and all 125 dosing regimens, providing precision insulin dosing recommendations to clinicians in just seconds. T...

Insulet Corporation

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its Omnipod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The Omnipod is a revolutionary and easy-to-use tubeless insulin pump tha...

Neural Analytics Inc.

Neural Analytics is creating products and services to measure, diagnose and track brain health with a current focus on Traumatic Brain Injury (TBI). NA combines leading edge data science with medical robotics to empower first responders and clinicians to accurately assess mild to severe TBI, including concussions. NA’s devices are portable, reliable...

Hygieia, Inc.

Hygieia, Inc. is an emerging diabetes health care company developing new ways to improve the effectiveness of therapy while reducing the cost of diabetes care. Hygieia’s first product is a handheld Diabetes Insulin Guidance System (DIGS™) designed to improve insulin therapy effectiveness for patients. DIGS works in a way that makes it a feasible ...

ProlX Pharmaceuticals, Corp.

ProlX Pharmaceuticals (ProlX) is a biopharmaceutical company dedicated to the discovery of novel therapeutics for the treatment of cancer. The Company is building a diversified pipeline utilizing a target-directed combinatorial chemistry approach to accelerate the design and development of small molecule drug leads. ProlX’s drug discovery program is focused on targeting redox regulation and sur...

Dance Pharma

Dance is a San Francisco based, global company focused exclusively on creating a line of small, patient friendly, pain-less, low cost insulin inhalers for the world diabetes market. In addition to providing inhaled insulin to those who have become insulin dependent, the company also intends to enable introduction of insulin much earlier in the disease proc...

Neural Intervention Technologies, Inc.

Neural Intervention Technologies (NIT) is a development stage medical device company focused on improving the quality of life of patients with blood vessel defects, including those of the brain that result in hemorrhagic stroke.NIT is developing ALGEL™-I and -II, novel embolic materials, into minimally invasive treatments for cerebral arteriovenous malformations and aneurysms. In addition, NIT w...

Mellitus Health, Inc.

Mellitus Health automates algorithmic dosing of insulin, offering clinicians precision recommendations in seconds. Founded in 2014 as Insulin Algorithms by Mayer B. Davidson, MD, Josh Davidson and Michael Margolese, the Los Angeles firm rebranded in 2018 as Mellitus Health, Inc.

Cyternex

Cyternex is a privately held biotechnology company developing novel small molecule anticancer agents for patients with advanced disease. Based in San Diego, Cyternex is investigating the role of dynamic, 3-D DNA structures in the regulation of known cancer genes and other aspects of tumor biology. By targeting these unique structures, Cyternex is able to develop drug candidates with the ability to...

Caprologics

Capralogics has manufactured a variety of novel polyclonal antibodies against Cell Membrane Receptors, Nuclear Components, Apoptosis Factors, Neuropeptides, Oncoproteins, Signaling Intermediates, Transcription Factors and Proteins Involved in Infectious D

Cyberkinetics Neurotechnology

Cyberkinetics Neurotechnology Systems, Inc. (OTCBB:CYKN) is a neurotechnology innovator focused on the commercialization of two proprietary platforms for direct neural sensing in the brain, real-time neural signal decoding technology, and neural stimulation. The Company's mission is to commercialize products based upon these powerful platform technologies that restore function, including limb move...

AlphaGenix, Inc

AlphaGenix is a provider of immunological products for the life science industry. These products cover virtually every area of biology including apoptosis, cancer, cardiology, cell cycle/regulation, DNA repair, immune system, infectious diseases, neuroscience, signal transduction and transcription factors. In addition, the company provides custom immunology services that include hybridoma develop...


More From BioPortfolio on "Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks